|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Contraception in older woman. |
| Volpe A; Silferi M; Genazzani AD; Genazzani AR |
| CONTRACEPTION. 1993 Mar;47(3):229-39. |
| Oral contraception (OC) in the premenopause has been recently proposed as treatment for control and prevention of |
| the putative symptoms typical of this period of life. Indeed, menstrual cycle disturbances and climacteric symptoms |
| frequently occur at this age. The major aim of normal contraception is resultant maintenance of normal sexual |
| activity. THe effects of one OC containing 20 mcg ethinyl estradiol (EE) and 150 mcg desogestrel (EE/DOG) were |
| studied. Treatment did not significantly modify both lipid metabolism (triglycerides, total cholesterol, HDL, LDL, Apo |
| A, Apo B) and clotting system (fibrinogen, PT, PTT, antithrombin III, fibrinopeptide A). A significant modifications of |
| oral glucose tolerance test (OGGT) occurred after EE/DOG treatment. Also, bone density was not modified during |
| estro-progestinic administration. From our experience, if there are not risk factors such as smoking, or hypertension, |
| the OCs could be used until menopause for absolute contraceptive efficacy, good tolerance, and lack of side effects. |
| (PubHealth.info Document ID: CONT2T 4535-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Contraception in older woman.", is(are) Volpe A; Silferi M; |
| Genazzani AD; Genazzani AR. The source of this article is "CONTRACEPTION. 1993 Mar;47(3):229-39.". This |
| article was published in 1993 in English language(s). (PubHealth.info® Document ID: CONT2T 4535-06. All rights |
| reserved with PubHealth.info) PIN: 9535 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |